Funds holding KalVista Pharmaceuticals Inc
137 funds declare a position · 30 ETFs and 107 other funds · 251.6M $· 67.4M SEK· 549.7K € · US4834971032
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 101 | Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,831 | 46.1K $ | 0.06 % | as of Feb 28, 2026 · Original filing |
| 102 | VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 2,756 | 55.5K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 103 | Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 2,682 | 54K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 104 | iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,567 | 68.4K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 105 | Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,465 | 49.6K $ | 0.03 % | as of Mar 31, 2026 · Original filing |
| 106 | ProShares Ultra Russell2000 ProShares Trust | 2,375 | 38.7K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 107 | ProShares UltraPro Russell2000 ProShares Trust | 2,370 | 38.6K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 108 | ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,334 | 38K $ | 0.04 % | as of Feb 28, 2026 · Original filing |
| 109 | Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 2,216 | 59.1K $ | 0.08 % | as of Apr 30, 2026 · Original filing |
| 110 | First Trust Small Cap BuyWrite Income ETF First Trust Exchange-Traded Fund VI | 2,206 | 44.4K $ | 0.20 % | as of Mar 31, 2026 · Original filing |
| 111 | Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 1,804 | 29.4K $ | 0.10 % | as of Feb 28, 2026 · Original filing |
| 112 | ProShares Russell 2000 High Income ETF ProShares Trust | 1,661 | 27K $ | 0.02 % | as of Feb 28, 2026 · Original filing |
| 113 | Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,514 | 40.4K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 114 | Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,371 | 22.3K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 115 | Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,162 | 18.9K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 116 | EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,094 | 22K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 117 | VIP Total Market Index Portfolio Variable Insurance Products Fund II | 936 | 18.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 118 | State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 911 | 18.3K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 119 | Penn Series Small Cap Index Fund Penn Series Funds Inc | 900 | 18.1K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 120 | Total Stock Market Index Trust John Hancock Variable Insurance Trust | 834 | 16.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 121 | Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 600 | 12.1K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 122 | TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 487 | 9.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 123 | ULTRA SMALL CAP PROFUND ProFunds | 433 | 11.5K $ | 0.02 % | as of Apr 30, 2026 · Original filing |
| 124 | Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 390 | 7.9K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 125 | State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 332 | 6.7K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 126 | Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 236 | 6.3K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 127 | Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 192 | 3.9K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 128 | PROFUND VP ULTRA SMALL CAP ProFunds | 128 | 2.6K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 129 | PROFUND VP SMALL CAP ProFunds | 97 | 2K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 130 | Russell 2000 Fund Rydex Series Funds | 89 | 1.8K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 131 | SMALL-CAP PROFUND ProFunds | 70 | 1.9K $ | 0.02 % | as of Apr 30, 2026 · Original filing |
| 132 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 53 | 1.1K $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 133 | ProShares Hedge Replication ETF ProShares Trust | 39 | 634.9 $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 134 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 38 | 764.9 $ | 0.03 % | as of Mar 31, 2026 · Original filing |
| 135 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 201.3 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 136 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 10 | 162.8 $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 137 | VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 549.7K € | 0.67 % | as of Dec 31, 2025 · Original filing |
Institutional managers
175 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Venrock Adviser, LLC | 6,474,485 | 130.3M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 4,961,108 | 99.9M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,768,712 | 96M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 4,573,530 | 92.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,795,897 | 76.4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,876,407 | 57.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 2,808,583 | 56.5M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,136,940 | 43M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,955,844 | 39.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,912,146 | 38.5M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,850,000 | 37.2M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 1,835,506 | 36.9M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 1,820,954 | 36.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,509,920 | 30.4M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 1,450,000 | 29.2M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 1,264,023 | 25.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,236,000 | 24.9M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 1,021,300 | 20.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 996,235 | 20.1M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 985,100 | 19.8M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 897,681 | 18.1M $ | as of Mar 31, 2026 |
| Freestone Grove Partners LP | 882,906 | 17.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 824,293 | 16.6M $ | as of Mar 31, 2026 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 805,762 | 16.2M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 675,000 | 13.6M $ | as of Mar 31, 2026 |